Research and Curriculum, SLUHN Family Medicine Residency-Warren, Phillipsburg, New Jersey, USA.
PGY2 Family Medicine, SLUHN Family Medicine Residency-Warren, Phillipsburg, New Jersey, USA.
Nutr Rev. 2022 Apr 8;80(5):1094-1104. doi: 10.1093/nutrit/nuab060.
The obesity epidemic is a main driver of the chronic disease epidemic; however, present treatment approaches have suboptimal efficacy.
To assess the efficacy of plant-predominant (vegan, vegetarian, plant-based whole foods [PBWFs]) diets in treating obesity and its main cardiometabolic sequelae: hyperlipidemia (HLD); indices of insulin resistance, glycemic control, and diabetes mellitus type 2 (DM2); and cardiovascular disease (CVD), including hypertension (HTN).
A systematic search of multiple databases was conducted for articles published between November 2019 and February 2020; databases searched included: PubMed, Medline (Ovid), Cochrane, CENTRAL, and CINAHL.
All interventional trials (randomized controlled trials [RCTs] and trials of non-randomized experimental design) that met the inclusion criteria (English language, duration of at least 4 weeks, primary end point congruent with above objectives, no major flaws in research design that would prevent interpretation) were included in the review. A total of 3135 articles were scanned and 84 were selected. The articles were collated and summarized in 2 evidence tables. Risk of bias for RCTs was assessed using the Cochrane Risk-of-Bias tool 2 as a guide. For non-randomized trials, higher risk of bias was assumed, and the JBI Critical Appraisal tool was used as a guide to determine inclusion.
Plant-based diets, in general, demonstrated improved weight control and cardiometabolic outcomes related to lipids, cardiovascular end points, blood pressure, insulin sensitivity, A1C, and fasting glucose, and a lower risk of diabetes compared with usual diets and in some cases standard health-oriented diets such as the American Heart Association (AHA), American Diabetic Association (ADA), and Mediterranean diets. Preliminary studies suggest plant-predominant diets practiced as part of healthy lifestyle interventions may stabilize or even reverse DM 2 and CVD. The acceptability and sustainability of plant-predominant diets where measured were generally similar to other health-oriented diets.
Plant-predominant diets can play a major role in reversing the obesity and chronic disease epidemics. In the setting of sustained lifestyle intervention programs, they may arrest or even reverse DM2 and CVD. Further higher-level RCTs are needed to confirm and expand on these findings.
肥胖症是慢性病流行的主要驱动因素;然而,目前的治疗方法效果并不理想。
评估以植物为主(纯素、素食、植物性全食物[PBWFs])饮食在治疗肥胖症及其主要心血管代谢后果方面的疗效:血脂异常(HLD);胰岛素抵抗、血糖控制和 2 型糖尿病(DM2)的指标;以及心血管疾病(CVD),包括高血压(HTN)。
对 2019 年 11 月至 2020 年 2 月期间发表的文章进行了多个数据库的系统搜索;搜索的数据库包括:PubMed、Medline(Ovid)、Cochrane、CENTRAL 和 CINAHL。
所有符合纳入标准(英语、持续时间至少 4 周、主要终点与上述目标一致、研究设计中没有重大缺陷,不会影响解释)的干预试验(随机对照试验[RCTs]和非随机实验设计试验)均被纳入审查。共扫描了 3135 篇文章,选择了 84 篇。将文章整理并总结在 2 个证据表中。使用 Cochrane 风险偏倚工具 2 作为指南评估 RCTs 的风险偏倚。对于非随机试验,假设存在更高的偏倚风险,并使用 JBI 批判性评估工具作为指南确定纳入标准。
一般来说,植物性饮食在控制体重和与脂质相关的心血管代谢结果方面表现出改善,包括心血管终点、血压、胰岛素敏感性、A1C 和空腹血糖,与常规饮食相比,糖尿病风险也较低,并且在某些情况下,与标准健康导向的饮食相比,如美国心脏协会(AHA)、美国糖尿病协会(ADA)和地中海饮食也是如此。初步研究表明,作为健康生活方式干预一部分的植物性饮食可能稳定甚至逆转 2 型糖尿病和 CVD。在可衡量的情况下,植物性饮食的可接受性和可持续性通常与其他健康导向的饮食相似。
植物性饮食可以在逆转肥胖和慢性病流行方面发挥重要作用。在持续的生活方式干预计划的背景下,它们可能会阻止甚至逆转 2 型糖尿病和 CVD。需要进一步进行更高水平的 RCT 来证实和扩展这些发现。